Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN ) today announced that it will report its third quarter 2025 financial and operating results on Tuesday, October 28, 2025, before the U.S. financial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback